Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats

Nephrology Dialysis Transplantation

Volumn 22, Issue 1, 2007, Pages 68-76

  Kazama, Itsuro ^a   Arata, Tomohiro ^a   Michimata, Mari ^a   Hatano, Ryo ^a   Suzuki, Michiko ^a   Miyama, Noriyuki ^b   Sanada, Satoru ^a   Sato, Akira ^b   Satomi, Susumu ^b   Ejima, Yutaka ^b   Sasaki, Sei ^c   Matsubara, Mitsunobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adenylate cyclase; Aquaporin 2; Combination therapy; Lithium chloride; Nephrogenic diabetes insipidus; OPC 31260

Indexed keywords

AQUAPORIN 2; ARGIPRESSIN[1 DEAMINO]; CREATININE; FUROSEMIDE; LITHIUM CHLORIDE; MOZAVAPTAN; POTASSIUM; SODIUM; UREA; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FLUID BALANCE; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LOW DRUG DOSE; MALE; MONOTHERAPY; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM BLOOD LEVEL; UREA BLOOD LEVEL; URINE OSMOLALITY; URINE VOLUME; WATER LOADING; WEIGHT REDUCTION; WESTERN BLOTTING;

ANIMALS; AQUAPORIN 2; BENZAZEPINES; DIABETES INSIPIDUS, NEPHROGENIC; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FUROSEMIDE; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; KIDNEY TUBULES, COLLECTING; LITHIUM; LITHIUM CHLORIDE; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, VASOPRESSIN;

EID: 33846020040     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl110     Document Type: Article

References (42)

1. Zerbe R, Stropez L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med 1980; 31: 315-327
2. Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967; 42: 790-806
3. Robertson GL, Aycinema P, Zerbe RL. Neurogenic disorders of osmoregulation. Am J Med 1982; 72: 339-353
4. Troyer A. Demeclocycline. Treatment for syndrome of inappropriate antidiuretic hormone secretion. JAMA 1977; 237: 2723-2726
5. Miller PD, Linas SL, Schrier RW. Plasma demeclocycline levels and nephrotoxicity: Correlation in hyponatremic cirrhotic patients. JAMA 1980; 243: 2513-2515
6. Fujisawa G, Ishikawa S, Tsuboi Y et al. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 1993; 44: 19-23
7. Fujita N, Ishikawa S, Sasaki S et al. Role of water channel AQP-CD in water retention in SIADH and cirrhotic rats. Am J Physiol 1995; 269: F926-F931
8. Saito T, Ishikawa S, Abe K et al. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). J Clin Endocrinol Metab 1997; 82: 1054-1057
9. Kazama I, Hatano R, Michimata M et al. BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats. Kidney Int 2005; 67: 1855-1867
10. Jope RS. Anti-bipolar therapy: Mechanism of action of lithium. Mol Psychiatry 1999; 4: 117-128
11. Singer I, Rotenberg D, Puschett JB. Lithium-induced nephrogenic diabetes insipidus: In vivo and in vitro studies. J Clin Invest 1972; 51: 1081-1091
12. Forrest JN, Cohen A, Torretti J et al. On the mechanism of lithium-induced diabetes insipidus in man and the rat. J Clin Invest 1974; 53: 1115-1123
13. White MG, Fetner CD. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 1975; 92: 390-392
14. Baker RS, Hurley RM, Feldman W. Treatment of recurrent syndrome of inappropriate secretion of antidiuretic hormone with lithium. J Pediatr 1977; 90: 480-481
15. Frias EC, Paz FB, Martinez AP et al. Inappropriate secretion of antidiuretic hormone and the effect of lithium in its treatment. J Pediatr 1980; 96: 153-155
16. Forrest JN, Cox M, Hong C et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173-177
17. Miyagawa CI. The pharmacologic management of the syndrome of inappropriate secretion of antidiuretic hormone. Drug Intell Clin Pharm 1986; 20: 527-531
18. Holstein-Rathlou NH. Lithium transport across biological membranes. Kidney Int 1990; 37 [Suppl 28]: S4-S9
19. Greger R. Possible sites of lithium transport in the nephron. Kidney Int 1990; 37 [Suppl 28]: S26-S30
20. Yamaki M, Kusano E, Tetsuka T et al. Cellular mechanism of lithium-induced nephrogenic diabetes insipidus in rats. Am J Physiol 1991; 261: F505-F511
21. Marples D, Christensen S, Christensen EI et al. Lithium-induced down regulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest 1995; 95: 1838-1845
22. Michimata M, Fujita S, Araki T et al. Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy. Kidney Int 2003; 63: 165-171
23. Sugawara M, Hashimoto K, Ota Z. Involvement of prostaglandin E2, cAMP, and vasopressin in lithium-induced polyuria. Am J Physiol 1988; 254: R863-R869
24. Ecelbarger CA, Nielsen S, Olson BR et al. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J Clin Invest 1997; 99: 1852-1863
25. Saito T, Higashiyama M, Nagasaka S et al. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int 2001; 60: 1266-1276
26. Verbalis JG. An experimental model of syndrome of inappropriate antidiuretic hormone secretion in the rat. Am J Physiol 1984; 247: E540-E553
27. Michimata M, Mizukami H, Kazama I et al. Vasopressin independent urinary concentration: Increased rBSC1 expression and enhanced countercurrent multiplier. Kidney Int 2003; 64: 933-938
28. 2 receptor in rat kidney. J Clin Invest 1994; 94: 1778-1783
29. Yamamoto T, Sasaki S, Fushimi K et al. Vasopressin increases AQP-CD water channel in apical membrane of collecting duct cells in Brattleboro rats. Am J Physiol 1995; 69: C655-C664
30. Christensen S. Effects of water deprivation in rats with polydipsia and polyuria due to long-term administration of lithium. Acta Pharmacol Toxicol 1974; 35: 201-211
31. Christensen S. Acute and chronic effects of vasopressin in rats with lithium-polyuria. Acta Pharmacol Toxicol 1976; 38: 241-253
32. Olsen OV, Schou M, Thomsen K. Administration of lithium to rats by different routes. Neuropsychobiology 1976; 2: 134-138
33. Gross P, Reinhard C, Marin-Grez M et al. Lithium treatment reduces the renal kallikrein excretion rate. Kidney Int 1990; 38: 124-128
34. Gross P, Schlenker A, Koeppen HI et al. Lithium interferes with renal kallikrein. Kidney Int 1990; 37: 369
35. Jamison RL, Maffly RH. The urinary concentrating mechanism. N Eng J Med 1976; 295: 1059-1067
36. - cotransporter and the thick ascending limb. Kidney Int 1989; 36: 418-426
37. Marumo R, Kaizuma S, Nogae S et al. Differential upregulation of rat Na-K-Cl cotransporter, rBSC1, mRNA in the thick ascending limb of Henle in different pathophysiological conditions. Kidney Int 1998; 54: 877-888
38. Nogae S, Michimata, M, Kanazawa M et al. Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending limb of Henle. Kidney Int 2000; 57: 2055-2063
39. Michimata M, Kazama I, Mizukami K et al. Urinary concentration defect and limited expression of sodium cotransporter, rBSC1, in a rat model of chronic renal failure. Nephron Physiol 2003; 93: 34-41
40. Hasler U, Mordasini D, Bianchi M et al. Dual influence of aldosterone on AQP2 expression in cultured renal collecting duct principal cells. J Biol Chem 2003; 278: 21 639-21 648
41. Reena R, Ming-Zhi Z, Min Z et al. Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. Am J Physiol Renal Physiol 2005; 288: F642-F649
42. Castrop H, Vitzthum H, Schumacher K et al. Low tonicity mediates a downregulation of cyclooxygenase-1 expression by furosemide in the rat renal papilla. J Am Soc Nephrol 2002; 13: 1136-1144